EP1235577A4 - Inhibiteurs de protease - Google Patents

Inhibiteurs de protease

Info

Publication number
EP1235577A4
EP1235577A4 EP00975608A EP00975608A EP1235577A4 EP 1235577 A4 EP1235577 A4 EP 1235577A4 EP 00975608 A EP00975608 A EP 00975608A EP 00975608 A EP00975608 A EP 00975608A EP 1235577 A4 EP1235577 A4 EP 1235577A4
Authority
EP
European Patent Office
Prior art keywords
protease inhibitors
protease
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00975608A
Other languages
German (de)
English (en)
Other versions
EP1235577A2 (fr
Inventor
Robert W Marquis Jr
Yu Ru
Daniel Frank Veber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1235577A2 publication Critical patent/EP1235577A2/fr
Publication of EP1235577A4 publication Critical patent/EP1235577A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EP00975608A 1999-11-10 2000-11-08 Inhibiteurs de protease Withdrawn EP1235577A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16451199P 1999-11-10 1999-11-10
US164511P 1999-11-10
PCT/US2000/030633 WO2001034565A2 (fr) 1999-11-10 2000-11-08 Inhibiteurs de protease

Publications (2)

Publication Number Publication Date
EP1235577A2 EP1235577A2 (fr) 2002-09-04
EP1235577A4 true EP1235577A4 (fr) 2003-04-09

Family

ID=22594826

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00975608A Withdrawn EP1235577A4 (fr) 1999-11-10 2000-11-08 Inhibiteurs de protease

Country Status (3)

Country Link
EP (1) EP1235577A4 (fr)
JP (1) JP2003513956A (fr)
WO (1) WO2001034565A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
BR9916488A (pt) * 1998-12-23 2001-10-09 Smithkline Beecham Corp Inibidores de protease
WO2001034600A1 (fr) 1999-11-10 2001-05-17 Smithkline Beecham Corporation Inhibiteurs de protease
JP2003513924A (ja) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
WO2001034159A1 (fr) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Inhibiteurs de protease
AU1588901A (en) 1999-11-10 2001-06-06 Smithkline Beecham Corporation Protease inhibitors
OA12323A (en) 2000-03-21 2006-05-15 Smithkline Beecham Corp Protease inhibitors.
CO5280093A1 (es) * 2000-04-18 2003-05-30 Smithkline Beecham Corp Metodos de tratamiento
HUP0301231A2 (hu) * 2000-06-14 2003-08-28 Smithkline Beecham Corp. Proteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2002017924A1 (fr) * 2000-09-01 2002-03-07 Smithkline Beecham Corporation Procede de traitement
JP2004196696A (ja) * 2002-12-18 2004-07-15 Kyowa Hakko Kogyo Co Ltd 関節炎の予防剤または治療剤
US20070293477A1 (en) * 2004-09-07 2007-12-20 Smithkline Beecham Corporation Novel Compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998005336A1 (fr) * 1996-08-08 1998-02-12 Smithkline Beecham Corporation Inhibiteurs de la protease a cysteine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9916488A (pt) * 1998-12-23 2001-10-09 Smithkline Beecham Corp Inibidores de protease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998005336A1 (fr) * 1996-08-08 1998-02-12 Smithkline Beecham Corporation Inhibiteurs de la protease a cysteine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0134565A3 *

Also Published As

Publication number Publication date
WO2001034565A3 (fr) 2001-10-04
EP1235577A2 (fr) 2002-09-04
JP2003513956A (ja) 2003-04-15
WO2001034565A2 (fr) 2001-05-17

Similar Documents

Publication Publication Date Title
PL349192A1 (en) Protease inhibitors
GB9912961D0 (en) Metalloprotease inhibitors
GB9900416D0 (en) Inhibitors
AU4344101A (en) Protease inhibitors
GB9917909D0 (en) Cysteine protease inhibitors
EP1093367A4 (fr) Inhibiteurs de proteases
IL145085A0 (en) Dihetero-substituted metalloprotease inhibitors
EP1067894A4 (fr) Inhibiteurs de protease
IL153421A0 (en) Protease inhibitors
EP1079821A4 (fr) Inhibiteurs de la protease
EP1232155A4 (fr) Inhibiteurs de protease
EP1153022A4 (fr) Inhibiteurs de protease
EP1229912A4 (fr) Inhibiteurs de protease
EP1231921A4 (fr) Inhibiteurs de proteases
EP1229914A4 (fr) Inhibiteurs de protease
EP1229915A4 (fr) Inhibiteurs de protease
EP1140897A4 (fr) Inhibiteurs de proteases
EP1086083A4 (fr) Inhibiteurs de proteases
IL151087A0 (en) Protease inhibitors
EP1233771A4 (fr) Inhibiteurs de protease
EP1229911A4 (fr) Inhibiteurs de proteases
EP1161237A4 (fr) Inhibiteurs de protease
EP1351930A4 (fr) Inhibiteurs de la protease
EP1173429A4 (fr) Inhibiteurs de protease
EP1231923A4 (fr) Inhibiteurs de protease

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020603

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

A4 Supplementary search report drawn up and despatched

Effective date: 20030221

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 31/38 B

Ipc: 7C 07D 495/04 B

Ipc: 7C 07D 409/14 B

Ipc: 7A 61P 19/10 B

Ipc: 7A 61P 19/08 B

Ipc: 7A 61K 31/55 A

17Q First examination report despatched

Effective date: 20030423

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030904